DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Yao JC, Pavel M, Lombard-Bohas C. et al.
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors: overall survival and circulating biomarkers from the randomized, phase III RADIANT-3 study.
J Clin Oncol 2016;
34 (32) 3906-3913
We do not assume any responsibility for the contents of the web pages of other providers.